Bo Nilsson Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

1/2024	A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile.
11/2022	Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome.
11/2020	Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.
1/2019	A case of systemic lupus erythematosus with C1q deficiency, increased serum interferon-α levels and high serum interferogenic activity.
1/2019	Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use.
1/2013	Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
1/2008	Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro.
5/2007	Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
6/2005	Cryoglobulin-induced cytokine production via FcgammaRIIa: inverse effects of complement blockade on the production of TNF-alpha and IL-10. Implications for the growth of malignant B-cell clones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Nilsson Research Topics

Disease

35	Inflammation (Inflammations) 01/2023 - 09/2005
16	Neoplasms (Cancer) 02/2021 - 04/2002
11	Thromboinflammation 01/2021 - 01/2013
10	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 12/2010
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 06/2005
9	COVID-19 08/2022 - 11/2020
9	Infections 06/2022 - 06/2004
8	Sepsis (Septicemia) 01/2022 - 08/2002
7	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 07/2003
7	Prostatic Neoplasms (Prostate Cancer) 06/2010 - 02/2005
6	Wounds and Injuries (Trauma) 12/2021 - 01/2017
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2016 - 08/2003
5	Thrombosis (Thrombus) 01/2022 - 09/2009
5	Melanoma (Melanoma, Malignant) 02/2011 - 05/2005
4	Reperfusion Injury 12/2023 - 06/2015
4	Hemolysis 10/2023 - 03/2002
4	Hereditary Complement Deficiency Diseases 01/2023 - 09/2007
4	Critical Illness (Critically Ill) 06/2022 - 12/2020
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2019
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 11/2020
3	Burns 12/2021 - 11/2017
3	Hemorrhagic Shock 01/2020 - 01/2019
3	Multiple Trauma (Multiple Injuries) 01/2019 - 11/2010
3	Arteriosclerosis 01/2018 - 01/2007
3	Multiple Sclerosis 01/2016 - 01/2013
3	Carcinoma (Carcinomatosis) 07/2008 - 06/2005
2	Atypical Hemolytic Uremic Syndrome 10/2023 - 10/2019
2	Thromboembolism 10/2023 - 01/2022
2	Rheumatoid Arthritis 01/2023 - 05/2007
2	Vascular Diseases (Vascular Disease) 11/2020 - 06/2020
2	Thrombocytopenia (Thrombopenia) 01/2019 - 08/2006
2	Stroke (Strokes) 01/2019 - 01/2007
2	Heart Failure 01/2018 - 01/2017
2	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 09/2007
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 08/2002
2	Diabetes Mellitus 11/2016 - 10/2014
2	Ischemia 01/2016 - 10/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 06/2014
2	Obesity 09/2015 - 06/2014
2	Insulin Resistance 09/2015 - 11/2005
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2014 - 01/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2013 - 01/2013

Drug/Important Bio-Agent (IBA)

51	Complement System Proteins (Complement)IBA 01/2024 - 03/2002
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2004
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2011
8	CytokinesIBA 06/2022 - 09/2004
7	Biocompatible Materials (Biomaterials)IBA 01/2022 - 01/2007
6	AutoantibodiesIBA 01/2024 - 01/2008
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2019 - 01/2004
5	Monoclonal AntibodiesIBA 11/2020 - 07/2003
4	Complement C3 (C3 Complement)IBA 08/2022 - 04/2010
4	Kallikreins (Kallikrein)IBA 01/2022 - 11/2016
4	KininsIBA 01/2022 - 11/2016
4	Heparin (Liquaemin)FDA LinkGeneric 04/2016 - 02/2010
3	LectinsIBA 01/2024 - 10/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2004
3	AntibodiesIBA 01/2024 - 01/2019
3	Thrombin FDA Link 01/2023 - 11/2010
3	compstatinIBA 08/2022 - 01/2019
3	Immunoglobulin G (IgG)IBA 06/2022 - 06/2005
3	ChemokinesIBA 01/2022 - 06/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
3	AntithrombinsIBA 03/2015 - 04/2004
3	Fluorouracil (Carac)FDA LinkGeneric 01/2009 - 10/2003
3	EnzymesIBA 03/2007 - 08/2002
2	LipopolysaccharidesIBA 01/2023 - 01/2020
2	AMY-101IBA 08/2022 - 11/2020
2	Immunoglobulin M (IgM)IBA 06/2022 - 06/2005
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2022 - 12/2020
2	complement C3d,gIBA 01/2021 - 05/2007
2	InterleukinsIBA 01/2021 - 06/2005
2	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2020
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 10/2019 - 01/2018
2	Carcinoembryonic AntigenIBA 05/2019 - 01/2004
2	LipidsIBA 01/2019 - 04/2016
2	Therapeutic UsesIBA 01/2019 - 09/2004
2	Fibrinogen (Factor I)FDA Link 01/2019 - 04/2004
2	Complement Inactivating AgentsIBA 01/2019 - 09/2009
2	PolymersIBA 01/2019 - 01/2016
2	glimepiride (Amarel)FDA LinkGeneric 01/2018 - 01/2017
2	Liraglutide FDA Link 01/2018 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2017
2	AnaphylatoxinsIBA 01/2017 - 09/2015
2	Peptides (Polypeptides)IBA 04/2016 - 11/2009
2	Blood Glucose (Blood Sugar)IBA 03/2015 - 06/2014
2	Insulin (Novolin)FDA Link 01/2015 - 02/2010
2	ButyrylcholinesteraseIBA 01/2015 - 11/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 03/2011 - 09/2010
2	AutoantigensIBA 04/2010 - 06/2005

Therapy/Procedure

18	Therapeutics 10/2023 - 10/2003
9	Transplantation 01/2019 - 12/2011
4	Immunotherapy 01/2009 - 06/2005
3	Radiotherapy 01/2009 - 10/2004
3	Prostatectomy (Retropubic Prostatectomy) 10/2008 - 11/2005
2	Kidney Transplantation 12/2023 - 12/2018
2	Critical Care (Surgical Intensive Care) 06/2022 - 01/2022
2	Renal Dialysis (Hemodialysis) 08/2021 - 01/2007
2	Stents 06/2020 - 01/2007
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2015 - 08/2011